Current issues relating to drug safety especially with regard to the use of biomarkers: A meeting report and progress update
Author:
Publisher
Elsevier BV
Subject
Pharmaceutical Science
Reference14 articles.
1. Pharmaco-metabonomic phenotyping and personalized drug treatment;Clayton;Nature,2006
2. Postmarketing drug dosage changes of 499 FDA-approved new molecular entities, 1980–1999;Cross;Pharmacoepidemiol. Drug Saf.,2002
3. Mechanism-based pharmacokinetic-pharmacodynamic modeling—a new classification of biomarkers;Danhof;Pharm. Res.,2005
4. The price of innovation: new estimates of drug development costs;DiMasi;J. Health Econ.,2003
5. Changes in prescribed drug doses after market introduction;Heerdink;Pharmacoepidemiol. Drug Saf.,2002
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Machine Learning in Drug Discovery: A Review;Artificial Intelligence Review;2021-08-11
2. Safety in Early Phase Studies;Statistical Methods in Biomarker and Early Clinical Development;2019
3. How scientific literature analysis yields innovative therapeutic hypothesis through integrative iterations;Current Opinion in Pharmacology;2018-10
4. Challenges in translational drug research in neuropathic and inflammatory pain: the prerequisites for a new paradigm;European Journal of Clinical Pharmacology;2017-09-11
5. Introduction;Statistical Methods for Evaluating Safety in Medical Product Development;2014-12-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3